I've been running rush orders in skincare manufacturing for about six years. Roughly 200 of them—give or take—I'd have to pull the exact number from our system, and honestly, I'm not going to do that right now. What I can tell you is that the same eight or nine questions come up before nearly every sourcing contract.

So I started sending them to clients upfront. Not to slow anyone down. Because every one of these shows up eventually, and it's a lot easier to answer them before the deadline than when the fill line is already running.

Here's the list, roughly in the order buyers ask.

1. What does "face moisturizer sourcing" actually mean—and why does it take weeks?

Sourcing isn't just placing an order. It's the whole chain: picking a base formula (or having one developed), confirming ingredient sources, running stability and compatibility tests, agreeing on MOQ and packaging, then scheduling production. For a brand-new formula, the testing alone typically runs four to eight weeks. Don't let anyone tell you otherwise.

What you can compress is everything around the testing—sample turnaround, paperwork, packaging proofs. I've seen a client go from first call to filled jars in 19 days when the base formula already existed. The difference is almost always whether they did the homework upfront.

If you're sourcing a private-label concept, start from a proven base. It'll save you a month.

2. How do I choose a face moisturizer for dry skin without testing ten samples?

Ask the formulator one question: what's the humectant-to-occlusive ratio? Dry-skin formulas need both—humectants like glycerin pull water in, occlusives like squalane or dimethicone hold it against the skin. If a formula is all humectant, it'll feel nice for twenty minutes and then leave skin tighter than before.

Second question: what's the TEWL data? Transepidermal water loss measurements tell you whether the formula actually does something—not just whether it spreads nicely on the back of your hand.

I remember one supplier pitching a "deeply hydrating" cream. Lovely texture. No occlusive in the top five ingredients. It passed a 24-hour patch test and looked great on the spec sheet—but by day three, users were complaining their skin felt drier.

3. Can the same face moisturizer for men work in a women's line, or do I need two formulas?

Usually, one base will carry both—with two tweaks: fragrance and texture. Men's formulas tend to run lighter and less fragrant, though that's as much marketing as physiology. The actives can be identical. I've sourced several ranges where the men's and women's SKUs were the same base, just a different pump and scent profile.

What'll hurt you is ignoring skin type within the men's line. A formula tuned for dry skin—heavy, rich—sits badly on oily skin regardless of gender. If your men's range is meant to cover the whole category, you need two bases, not one.

I learned that one the hard way in 2023. A client insisted on a single universal base for a 12-SKU men's range. Six weeks later, we were reformulating the oil-control variants because one formula wasn't cutting it.

4. What makes a "good" face moisturizer on paper?

Not the ingredient list length. That's the first thing rookie buyers overvalue. I do not mean that ingredient lists are irrelevant—I mean the opposite. A 45-ingredient formula isn't automatically better than a 20-ingredient one; it's usually just marketed harder.

Look at three things: the preservative system, the emulsifier system, and the packaging compatibility data. A weak preservative system will fail on shelf life. A cheap emulsifier will separate at 40°C. Packaging that hasn't been compatibility-tested will leach, react, or fail a closure test right when you're about to ship.

If a supplier can't show you stability data at 40°C/75% RH for three months, walk. Not because the formula is bad—because you can't tell if it's bad.

FTC advertising guidance is blunt about this:

Claims must be truthful and not misleading, and must be substantiated with evidence. Source: ftc.gov, Business Guidance on Advertising.

That includes the claims you print on the front of the jar. "Long-lasting hydration" needs to be substantiable. So does "dermatologist-tested." Ask for the study.

5. What's the safest way to source a face moisturizer with SPF?

In the US, this is where sourcing gets serious. Sunscreen actives in a moisturizer push it into OTC drug territory under the FDA's sunscreen monograph (21 CFR Part 352). That means Drug Facts labeling, batch records, and an FDA-registered facility. Not every contract manufacturer is set up for it—and not every quote you receive will tell you that.

In the EU, it's the Cosmetics Regulation (EC) No 1223/2009, and you can't slap "SPF 30" on the label without testing to ISO 24444 (in vivo) or ISO 24443 (in vitro, for UVA-PF). Those tests aren't cheap, and they take time.

I've seen more than one brand get an "SPF 30 moisturizer" quote from a supplier who turned out not to have a drug registration. It's a five-minute question to ask. Ask it before the PO.

6. What changes when sourcing a face moisturizer for sensitive skin?

Three real changes and one fake one. Real: strip fragrance (including masking fragrance—it's still fragrance), simplify the preservative system to avoid common sensitizers like methylisothiazolinone, and run HRIPT or patch testing on the finished formula, not just the raw ingredients.

The fake change: "hypoallergenic." There's no regulatory definition for the term. Per FTC guidance, if you print it, you'd better have evidence behind it. Same goes for "natural" under the FTC Green Guides (16 CFR Part 260)—no fixed definition, and the claim still needs substantiation.

I had a client once who assumed "natural" meant the same thing to every formulator. Didn't verify. Turned out one lab read it as no synthetic preservatives at all; another read it as nature-identical ingredients allowed. Two formulas arrived with completely different preservation profiles. Both were "natural" under their respective house definitions.

7. What's the question most buyers never ask—but should?

Who owns the formula after the contract ends?

If you're on an ODM model, the manufacturer typically retains IP rights to the formula. That's fine—until you want to move suppliers, license the formula to another brand, or sell the company. If you're on an OEM model where you funded development, negotiate ownership upfront. Get it in the master services agreement, in plain language, before you sign anything.

Looking back, I should have flagged that to a client in 2024. She'd funded a full custom development—low six figures once you counted testing, MOQ, and packaging—and assumed she owned the formula. The contract said the manufacturer did. The brand was sold eighteen months later. That single clause came back as a redesign estimate she hadn't budgeted for.

8. How fast can a rush order actually move?

Honest answer: stability testing can't be rushed without compromising the data. Three months at 40°C is three months. What you can rush is everything else—sampling (I've turned samples around in 72 hours), packaging approval, documentation, and fill slots.

In March 2024, a client called me 36 hours before their Q2 drop was supposed to go live. Their previous supplier had shipped the wrong base—the dry-skin version went into the normal-to-oily SKU. We had existing stability data on the correct base, an open fill slot, and a contract packager 40 minutes away. We shipped in nine days. That's about as fast as real rush gets. Anyone promising you 72 hours on a new formula is telling the truth about the invoice and lying about the data.

The clients who ship on time aren't the ones who call me at the last minute. They're the ones who call me when there's still time to fail safely.

That's the list. If any of these answers lands at "I don't know" with your current supplier, that's the conversation worth having before you sign.